Salesforce Rallies on Strong Quarter and Anthropic Tie-Up, But Proof of Organic AI Growth Still Needed

What happened

Salesforce shares surged after the company reported a strong fiscal second quarter and announced an expanded partnership with Anthropic, defying the recent bearish sentiment that had pushed the stock to its lowest levels in years. The quarterly results likely showed robust current remaining performance obligation (cRPO) growth and perhaps early signs of organic acceleration, while the Anthropic collaboration promises deeper integration of advanced AI models into Salesforce's platform. However, the core investment question remains whether Agentforce can offset potential seat compression and whether AI monetization will translate into durable revenue growth rather than one-time boosts. The stock's rally may reflect short-term relief, but the market has been quick to punish Salesforce for any guidance softness, and the partnership's financial impact is uncertain. Investors should watch whether the strong report was driven by acquisitions or genuine organic improvement, and whether management raises guidance for the second half of fiscal 2027.

Implication

The strong quarter and Anthropic partnership reduce the probability of the bear case, but do not eliminate the risk that AI-related seat compression will erode renewal economics. Short-term traders may ride the momentum, but long-term investors should require evidence that cRPO stays above 14% and that Agentforce Apps growth is not masked by acquisition contributions. The partnership could enhance Salesforce's AI capabilities, but it also underscores the company's reliance on external models rather than building fully proprietary AI, which may limit differentiation. If the recent rally pushes the stock toward the upper end of the WAIT range, trimming into strength may be prudent while waiting for the Q3 FY27 print. A sustained move above $195 would require the market to believe that AI is adding to ACV rather than just replacing seat revenue.

Thesis delta

The thesis shifts from 'WAIT' to a more balanced 'WAIT with positive bias' as the strong quarter and Anthropic partnership provide early evidence that AI monetization is progressing. However, the master report's core concern—that cRPO and organic growth need to confirm a durable reacceleration—remains unresolved until at least Q3 FY27. If subsequent data show organic subscription growth accelerating and cRPO holding above 14%, the rating could upgrade to 'BUY' on dips, but for now the risk/reward is less attractive after the rally.